Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024, 168(4):311-318 | DOI: 10.5507/bp.2024.016

The renoprotective effect of Tibolone in sepsis-induced acute kidney injury

Ejder Saylav Bora1, Duygu Burcu Arda2, Oytun Erbas3
1 Department of Emergency Medicine, Faculty of Medicine, Izmir Katip Çelebi University, Izmir, Turkey
2 Department of Pediatrics, Faculty of Medicine, Cerrahpaºa University, Istanbul, Turkey
3 Depatment of Physiology, Faculty of Medicine, Demiroğlu Bilim University Istanbul, Turkey

Introduction: Sepsis-induced acute kidney injury (AKI) remains a major challenge in intensive care, contributing significantly to morbidity and mortality. Tibolone, known for its neuroprotective and hormonal properties, has not been explored for its potential in AKI management. This study investigates the protective effects of Tibolone and its underlying mechanisms involving Sirtuin-1 (SIRT1) and Yes-Associated Protein (YAP) in a rat sepsis model.

Materials and Methods: Thirty-six female Wistar albino rats underwent cecal ligation and puncture (CLP) to induce sepsis. They were randomly assigned to control, CLP+Saline, and CLP+Tibolone groups. Tibolone was administered intraperitoneally. Biomarkers, including Sirtuin (SIRT1), Yes-associated protein (YAP), Tumor necrosis factor (TNF-α), High mobility group box 1 (HMGB1), malondialdehyde (MDA), creatinine, and urea, were assessed. Histopathological examination evaluated renal damage.

Results: Tibolone administration significantly reduced plasma TNF-α, HMGB1, MDA, creatinine, and urea levels compared to the CLP+Saline group. Moreover, Tibolone elevated SIRT1 and YAP levels in kidney tissues. Histopathological examination demonstrated a significant decrease in tubular epithelial necrosis, luminal debris, dilatation, hemorrhage, and interstitial inflammation in Tibolone-treated rats.

Conclusion: This study unveils the protective role of Tibolone against sepsis-induced AKI in rats. The improvements in inflammatory and oxidative biomarkers and histological evidence suggest Tibolone's potential as a therapeutic intervention in sepsis-associated kidney injury. The upregulation of SIRT1 and YAP indicates their involvement in Tibolone's renoprotective mechanisms. Further investigations are warranted to explore Tibolone's translational potential in human sepsis-induced AKI.

Keywords: Tibolone, acute renal injury, sepsis, anti-inflammatory

Received: December 23, 2023; Revised: April 18, 2024; Accepted: May 7, 2024; Prepublished online: May 22, 2024; Published: November 22, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bora, E.S., Arda, D.B., & Erbas, O. (2024). The renoprotective effect of Tibolone in sepsis-induced acute kidney injury. Biomedical papers168(4), 311-318. doi: 10.5507/bp.2024.016
Download citation

References

  1. Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M; Sepsis Definitions Task Force. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016:23;315(8):775-87. doi: 10.1001/jama.2016.0289 Go to original source... Go to PubMed...
  2. Gotts JE, Matthay MA. Sepsis: Pathophysiology and clinical management. BMJ 2016;353:i1585. doi:10.1136/bmj.i1585 Go to original source... Go to PubMed...
  3. Delano MJ, Ward PA. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J Clin Invest.2016;126(1):23-31. doi:10.1172/JCI82224 Go to original source... Go to PubMed...
  4. Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm 2013;2013:165974. doi:10.1155/2013/165974 Go to original source... Go to PubMed...
  5. Erdogan A, Erdogan MA, Kara AY, Bora S, Yigitturk G, Erbas O. Effect of fluid resuscitation on acute lung injury in a rat model of sepsis. Bratisl Lek Listy 2021;122(4):280-6. doi: 10.4149/BLL_2021_047 Go to original source... Go to PubMed...
  6. Cossart YE. The rise and fall of infectious diseases: Australian perspectives, 1914-2014. Med J Aust 2014;201(1 Suppl):S11-S14. doi:10.5694/mja14.00112 Go to original source... Go to PubMed...
  7. Nedeva C, Menassa J, Puthalakath H. Sepsis: Inflammation Is a Necessary Evil. Front Cell Dev Biol 2019;7:108. doi:10.3389/fcell.2019.00108 Go to original source... Go to PubMed...
  8. Zarjou A, Agarwal A. Sepsis and acute kidney injury. J Am Soc Nephrol 2011;22(6):999-1006. doi:10.1681/ASN.2010050484 Go to original source... Go to PubMed...
  9. Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence 2014;5(1):36-44. doi:10.4161/viru.25436 Go to original source... Go to PubMed...
  10. Cepinskas G, Wilson J. Inflammatory response in microvascular endothelium in sepsis: role of oxidants. J Clin Biochem Nutr 2008;42(3):175-84. doi: 10.3164/jcbn.2008026 Go to original source... Go to PubMed...
  11. Oliveira FRMB, Assreuy J, Sordi R. The role of nitric oxide in sepsis-associated kidney injury. Biosci Rep 2022;42(7):BSR20220093. doi: 10.1042/BSR20220093 Go to original source... Go to PubMed...
  12. Lopes-Pires M, Frade-Guanaes JO, Quinlan GJ. Clotting Dysfunction in Sepsis: A Role for ROS and Potential for Therapeutic Intervention. Antioxidants (Basel) 2021;11(1):88. doi: 10.3390/antiox11010088 Go to original source... Go to PubMed...
  13. Kloosterboer HJ. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 2001;76(1-5):231-8. doi:10.1016/s0960-0760(01)00044-9 Go to original source... Go to PubMed...
  14. González-Giraldo Y, Forero DA, Echeverria V, Garcia-Segura LM, Barreto GE. Tibolone attenuates inflammatory response by palmitic acid and preserves mitochondrial membrane potential in astrocytic cells through estrogen receptor beta. Mol Cell Endocrinol 2019;486:65-78. doi:10.1016/j.mce.2019.02.017 Go to original source... Go to PubMed...
  15. Rymer JM. The effects of Tibolone. Gynecol Endocrinol 1998;12(3):213-20. doi:10.3109/09513599809015548 Go to original source... Go to PubMed...
  16. Rymer J, Chapman MG, Fogelman I. Effect of Tibolone on postmenopausal bone loss. Osteoporos Int 1994;4(6):314-9. doi:10.1007/BF01622189 Go to original source... Go to PubMed...
  17. Kulkarni J, Gavrilidis E, Wang W, Worsley R, Fitzgerald PB, Gurvich C, Van Rheenen T, Berk M, Burger H. Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age. Mol Psychiatry 2015;20(6):695-702. doi: 10.1038/mp.2014.33 Go to original source... Go to PubMed...
  18. Wang X, Buechler NL, Woodruff AG, Long DL, Zabalawi M, Yoza BK, McCall CE, Vachharajani V. Sirtuins and Immuno-Metabolism of Sepsis. Int J Mol Sci 2018;19(9):2738. doi: 10.3390/ijms19092738 Go to original source... Go to PubMed...
  19. Gao R, Ma Z, Hu Y, Chen J, Shetty S, Fu J. SIRT1 restrains lung inflammasome activation in a murine model of sepsis. Am J Physiol Lung Cell Mol Physiol 2015;308(8):L847-L853. doi:10.1152/ajplung.00274.2014 Go to original source... Go to PubMed...
  20. Gao Q, Zhu H. The Overexpression of Sirtuin1 (SIRT1) Alleviated Lipopolysaccharide (LPS)-Induced Acute Kidney Injury (AKI) via Inhibiting the Activation of Nucleotide-Binding Oligomerization Domain-Like Receptors (NLR) Family Pyrin Domain Containing 3 (NLRP3) Inflammasome Med Sci Monit 2019;25:2718-26. doi:10.12659/MSM.913146 Go to original source... Go to PubMed...
  21. Schwartzman M, Reginensi A, Wong JS, Basgen JM, Meliambro K, Nicholas SB, D'Agati V, McNeill H, Campbell KN. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure. J Am Soc Nephrol 2016;27(1):216-26. doi: 10.1681/ASN.2014090916 Go to original source... Go to PubMed...
  22. Zhang J, Xu Q, Ren F, Liu Y, Cai R, Yao Y, Zhou MS. Inhibition of YAP activation attenuates renal injury and fibrosis in angiotensin II hypertensive mice. Can J Physiol Pharmacol 2021;99(10):1000-6. doi: 10.1139/cjpp-2021-0033 Go to original source... Go to PubMed...
  23. Erbaº O, Taºkiran D. Sepsis-induced changes in behavioral stereotypy in rats; involvement of tumor necrosis factor-alpha, oxidative stress, and dopamine turnover. J Surg Res 2014;186(1):262-8. doi:10.1016/j.jss.2013.08.001 Go to original source... Go to PubMed...
  24. Chen JK, Chen J, Thomas G, Kozma SC, Harris RC. S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 2009;297(3):F585-93. doi: 10.1152/ajprenal.00186.2009 Go to original source... Go to PubMed...
  25. Chen J, Chen JK, Conway EM, Harris RC. Survivin mediates renal proximal tubule recovery from AKI. J Am Soc Nephrol. 2013 Dec;24(12):2023-33. doi: 10.1681/ASN.2013010076 Go to original source... Go to PubMed...
  26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54. doi:10.1006/abio.1976.9999 Go to original source... Go to PubMed...
  27. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294(7):813-8. doi: 10.1001/jama.294.7.813 Go to original source... Go to PubMed...
  28. Shum HP, Chan KC, Kwan MC, Yeung AW, Cheung EW, Yan WW. Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury. Ther Apher Dial 2013;17(3):305-10. doi:10.1111/j.1744-9987.2012.01147.x Go to original source... Go to PubMed...
  29. Baºol N, Erbaº O, Çavuºoğlu T, Meral A, Ateº U. Beneficial effects of agomelatine in experimental model of sepsis-related acute kidney injury. Ulus Travma Acil Cerrahi Derg 2016;22(2):121-6. doi:10.5505/tjtes.2015.29499 Go to original source... Go to PubMed...
  30. de Medeiros AR, Lamas AZ, Caliman IF, Dalpiaz PL, Firmes LB, de Abreu GR, Moysés MR, Lemos EM, dos Reis AM, Bissoli NS. Tibolone has anti-inflammatory effects in estrogen-deficient female rats on the natriuretic peptide system and TNF-alpha. Regul Pept 2012;179(1-3):55-60. doi: 10.1016/j.regpep.2012.08.015 Go to original source... Go to PubMed...
  31. Rezan Karaali, Ejder Saylav Bora, Hüseyin Acar, Yiğit Uyanikgil, Ibrahim Halil Sever, Mumin Alper Erdogan and Oytun Erbaº, 2023. Exploring Beta Blockers' Efficacy in Sepsis-Induced Acute Lung Injury and HMGB1-sRAGE Interaction. Int J Pharmacol. 2023;19:296-304. doi: 10.3923/ijp.2023.296.304 Go to original source...
  32. Wang H, Zhu S, Zhou R, Li W, Sama AE. Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Rev Mol Med 2008;10:e32. doi: 10.1017/S1462399408000884 Go to original source... Go to PubMed...
  33. Zhao F, Fang Y, Deng S, Li X, Zhou Y, Gong Y, Zhu H, Wang W. Glycyrrhizin Protects Rats from Sepsis by Blocking HMGB1 Signaling. Biomed Res Int 2017;2017:9719647. doi: 10.1155/2017/9719647 Go to original source... Go to PubMed...
  34. Fan H, Yang HC, You L, Wang YY, He WJ, Hao CM. The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury. Kidney Int 2013;83(3):404-13. doi:10.1038/ki.2012.394 Go to original source... Go to PubMed...
  35. Elangovan S, Ramachandran S, Venkatesan N, Ananth S, Gnana-Prakasam JP, Martin PM, Browning DD, Schoenlein PV, Prasad PD, Ganapathy V, Thangaraju M. SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer. Cancer Res 2011;71(21):6654-64. doi: 10.1158/0008-5472.CAN-11-1446 Go to original source... Go to PubMed...
  36. Hasegawa K, Wakino S, Simic P, Sakamaki Y, Minakuchi H, Fujimura K, Hosoya K, Komatsu M, Kaneko Y, Kanda T, Kubota E, Tokuyama H, Hayashi K, Guarente L, Itoh H. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med 2013;19(11):1496-504. doi: 10.1038/nm.3363 Go to original source... Go to PubMed...
  37. Cheng X, Zhang S, Wen Y, Shi Z. Clinical significance of sirtuin 1 level in sepsis: correlation with disease risk, severity, and mortality risk. Braz J Med Biol Res 2020;54(2):e10271. doi: 10.1590/1414-431X202010271 Go to original source... Go to PubMed...
  38. Yi L, Huang X, Guo F, Zhou Z, Chang M, Tang J, Huan J. Lipopolysaccharide Induces Human Pulmonary Micro-Vascular Endothelial Apoptosis via the YAP Signaling Pathway. Front Cell Infect Microbiol 2016;6:133. doi: 10.3389/fcimb.2016.00133 Go to original source... Go to PubMed...
  39. Schwartzman M, Reginensi A, Wong JS, Basgen JM, Meliambro K, Nicholas SB, D'Agati V, McNeill H, Campbell KN. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure. J Am Soc Nephrol 2016;27(1):216-26. doi: 10.1681/ASN.2014090916 Go to original source... Go to PubMed...
  40. Chen J, You H, Li Y, Xu Y, He Q, Harris RC. EGF Receptor-Dependent YAP Activation Is Important for Renal Recovery from AKI. J Am Soc Nephrol 2018;29(9):2372-85. doi:10.1681/ASN.2017121272 Go to original source... Go to PubMed...
  41. Zheng Z, Li C, Shao G, Li J, Xu K, Zhao Z, Zhang Z, Liu J, Wu H. Hippo-YAP/MCP-1 mediated tubular maladaptive repair promote inflammation in renal failed recovery after ischemic AKI. Cell Death Dis 2021;12(8):754. doi: 10.1038/s41419-021-04041-8 Go to original source... Go to PubMed...
  42. Aslan A, van den Heuvel MC, Stegeman CA, Popa ER, Leliveld AM, Molema G, Zijlstra JG, Moser J, van Meurs M. Kidney histopathology in lethal human sepsis. Crit Care 2018;22(1):359. doi: 10.1186/s13054-018-2287-3 Go to original source... Go to PubMed...
  43. Segura-Uribe JJ, García-de la Torre P, Castillo-Mendieta T, Bribiesca-Cruz I, Orozco-Suárez S, Soriano-Ursúa MA, Pinto-Almazán R, Fuentes-Venado CE, Guerra-Araiza C. Tibolone Improves Memory and Decreases the Content of Amyloid-β Peptides and Tau Protein in the Hippocampus of a Murine Model of Alzheimer's Disease. J Alzheimers Dis 2022;90(4):1437-47. doi: 10.3233/JAD-220434 Go to original source... Go to PubMed...
  44. Yin X, Yin Y, Cao FL, Chen YF, Peng Y, Hou WG, Sun SK, Luo ZJ. Tanshinone IIA attenuates the inflammatory response and apoptosis after traumatic injury of the spinal cord in adult rats. PLoS One 2012;7(6):e38381. doi: 10.1371/journal.pone.0038381 Go to original source... Go to PubMed...
  45. Kulkarni J, Gavrilidis E, Thomas N, Hudaib AR, Worsley R, Thew C, Bleeker C, Gurvich C. Tibolone improves depression in women through the menopause transition: A double-blind randomized controlled trial of adjunctive tibolone. J Affect Disord 2018;236:88-92. doi: 10.1016/j.jad.2018.04.103 Go to original source... Go to PubMed...
  46. Campisi R, Marengo FD. Cardiovascular effects of Tibolone: a selective tissue estrogenic activity regulator. Cardiovasc Drug Rev 2007;25(2):132-45. doi:10.1111/j.1527-3466.2007.00007.x Go to original source... Go to PubMed...
  47. Hidalgo-Lanussa O, Ávila-Rodriguez M, Baez-Jurado E, Zamudio J, Echeverria V, Garcia-Segura LM, Barreto GE. Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta. Mol Neurobiol 2018;55(7):5462-77. doi: 10.1007/s12035-017-0777-y Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.